Bristol-Myers Squibb Co CDR (CAD Hedged) BMY
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 2.04B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 2.50
- Price/Sales
- 0.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Value
- Total Number of Employees
- 32,500
- Website
- https://www.bms.com
Valuation
|
Metric
|
BMY
|
|---|---|
Price/Earnings (Normalized) | 2.50 |
Price/Book Value | 1.45 |
Price/Sales | 0.67 |
Price/Cash Flow | 2.24 |
Price/Earnings
BMY
Financial Strength
|
Metric
|
BMY
|
|---|---|
Quick Ratio | 1.29 |
Current Ratio | 1.53 |
Interest Coverage | 7.88 |
Quick Ratio
BMY
Profitability
|
Metric
|
BMY
|
|---|---|
Return on Assets (Normalized) | 14.59% |
Return on Equity (Normalized) | 68.67% |
Return on Invested Capital (Normalized) | 21.69% |
Return on Assets
BMY
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|$%q%^xr | LOCK|&&y | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|^W>f#x | LOCK|!Q | $621B | |||
| AbbVie Inc
ABBV
| LOCK|nB>!<kS | LOCK|!% | $503B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|<vJXbgyH | LOCK|?Q | $379B | |||
| Merck & Co Inc
MRK
| LOCK|<VnZ#P | LOCK|P& | $370B | |||
| Novartis AG ADR
NVS
| LOCK|H%mD$^TK | LOCK|<Y! | $292B | |||
| AstraZeneca PLC
AZN
| LOCK|?&GkCyhw | LOCK|jG> | $262B | |||
| Amgen Inc
AMGN
| LOCK|&j^cF$# | LOCK|T>x | $237B | |||
| Gilead Sciences Inc
GILD
| LOCK|w$P$S@# | LOCK|Q#! | $190B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|^?dD^g | LOCK|W> | $173B |
United States